CN Patent
CN118541148A — 增强抗老花眼作用的碳酰胆碱制剂
Assigned to Vision Therapy Co ltd · Expires 2024-08-23 · 2y expired
What this patent protects
本公开涉及包含碳酰胆碱的眼用制剂,用于制备包含碳酰胆碱、粘度剂、张度剂、缓冲剂和7至7.6之间的pH的眼用制剂的方法,以及通过向有此需要的受试者施用包含碳酰胆碱的眼用制剂来治疗老花眼和其他眼科病症如远视的方法。
USPTO Abstract
本公开涉及包含碳酰胆碱的眼用制剂,用于制备包含碳酰胆碱、粘度剂、张度剂、缓冲剂和7至7.6之间的pH的眼用制剂的方法,以及通过向有此需要的受试者施用包含碳酰胆碱的眼用制剂来治疗老花眼和其他眼科病症如远视的方法。
Drugs covered by this patent
- Alphagan (BRIMONIDINE TARTRATE) · Senju Pharmaceutical Co., Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.